Key stats
About GUOTAI ASSET MANAGEMENT CO GUOTAI CSI BIO-MEDICINE ETF
Home page
Inception date
Apr 18, 2019
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Guotai Asset Management Co., Ltd.
ISIN
CNE100003KR2
Closely track underlying indexTightly track the target and minimize the deviation
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
512290 assets under management is 3.50 B CNY. It's fallen 5.22% over the last month.
512290 fund flows account for −547.51 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 512290 doesn't pay dividends to its holders.
512290 shares are issued by Guotai Asset Management Co., Ltd. under the brand Guotai. The ETF was launched on Apr 18, 2019, and its management style is Passive.
512290 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
512290 follows the CSI Biomedical Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
512290 price has risen by 0.84% over the last month, and its yearly performance shows a 10.00% increase. See more dynamics on 512290 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 2.43% over the last month, showed a 1.80% increase in three-month performance and has increased by 12.58% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 2.43% over the last month, showed a 1.80% increase in three-month performance and has increased by 12.58% in a year.
512290 trades at a premium (0.09%) meaning the ETF is trading at a higher price than the calculated NAV.